Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2013 Publisher: Omega Pharma Ltd., 1<sup>st</sup> Floor, 32 Vauxhall Bridge Road, LONDON, SW1V 2SA, United Kingdom
Phillips' Milk of Magnesia.
| Pharmaceutical Form |
|---|
|
Oral Suspension. |
Magnesium Hydroxide BP 415 mg per 5 ml suspension.
| Active Ingredient | Description | |
|---|---|---|
| Magnesium hydroxide |
Magnesium hydroxide is practically insoluble in water and solution is not effected until the hydroxide reacts with hydrochloric acid in the stomach to form magnesium chloride. Its neutralising action is almost equal to that of sodium bicarbonate. When the dose is in excess of that required to neutralise the acid the intragastric pH may reach pH 8 or 9. Acid rebound following magnesium hydroxide is clinically insignificant. Magnesium hydroxide has an indirect cathartic effect resulting from water retention in the intestinal lumen. |
| List of Excipients |
|---|
|
Sodium Hydrogen Carbonate EP |
Blue HDPE bottles with white HDPE screw turn tamper evident inner cap and external click on dosing cap. Pack size 100ml and 200ml.
Omega Pharma Ltd., 1st Floor, 32 Vauxhall Bridge Road, LONDON, SW1V 2SA, United Kingdom
PL 02855/0072
22nd March 1999
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
